[1]
2026. INTENSIVE CARE FOR COMPLICATIONS FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION DURING THE AGRANULOCYTOSIS PERIOD IN PATIENTS WITH AUTOIMMUNE DISEASES. International journal of medical sciences. 6, 4 (Apr. 2026), 764–769. DOI:https://doi.org/10.55640/.